Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -614,741 | -361,450 | -182,221 | -886,116 | -609,931 |
| Depreciation Amortization | 53,555 | 34,784 | 17,006 | 54,368 | 39,606 |
| Accounts receivable | -35,070 | -26,099 | -32,882 | -24,238 | -29,717 |
| Accounts payable and accrued liabilities | 75,564 | 2,036 | -14,215 | 92,354 | 57,368 |
| Other Working Capital | -27,209 | -85,135 | -92,073 | 402,381 | 390,717 |
| Other Operating Activity | 56,084 | 54,373 | 58,224 | 82,824 | 69,510 |
| Operating Cash Flow | $-491,817 | $-381,491 | $-246,161 | $-278,427 | $-82,447 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -278,737 | -281,067 | 143,205 | -300,521 | -125,476 |
| PPE Investments | -48,693 | -36,275 | -19,617 | -140,156 | -101,351 |
| Purchase Of Investment | -9,900 | -9,900 | -9,900 | N/A | 30,000 |
| Sale Of Investment | N/A | N/A | N/A | 30,000 | N/A |
| Other Investing Activity | -300 | -300 | 0 | -7,000 | 0 |
| Investing Cash Flow | $-337,630 | $-327,542 | $113,688 | $-417,677 | $-196,827 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -30,000 |
| Common Stock Issued | 280,957 | 251,010 | 53,869 | 853,184 | 812,842 |
| Other Financing Activity | 496,072 | 491,872 | 0 | -30,000 | 0 |
| Financing Cash Flow | $777,029 | $742,882 | $53,869 | $823,184 | $782,842 |
| Exchange Rate Effect | 1,946 | -196 | -631 | -83 | -449 |
| Beginning Cash Position | 549,628 | 549,628 | 549,628 | 422,631 | 422,631 |
| End Cash Position | 499,156 | 583,281 | 470,393 | 549,628 | 925,750 |
| Net Cash Flow | $-50,472 | $33,653 | $-79,235 | $126,997 | $503,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | -491,817 | -381,491 | -246,161 | -278,427 | -82,447 |
| Capital Expenditure | -48,693 | -36,275 | -19,617 | -140,156 | -101,351 |
| Free Cash Flow | -540,510 | -417,766 | -265,778 | -418,583 | -183,798 |